Keywords: Breast cancer; molecular taxonomy; gene expression profiling; luminal; HER2; basal-like; next generation sequencing; molecular prognostic assays;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Male breast cancer; Estrogen and progesterone receptors; Ki-67; HER2; Aromatase inhibitors; Tamoxifen; Fulvestrant;
Keywords: Breast cancer; Brain metastases; Prognostic factors; Tumour subtypes; Oestrogen receptor; Progesterone receptor; HER2;
Keywords: G17DT; CCK-B Receptor; Proton Pump Inhibitors; PPIs; CCK-BR; cholecystokinin-B receptor; ECL; enterochromaffin-like; EGFR; epidermal growth factor receptor; ERK; extracellular signal-regulated kinase; HER2; human epidermal growth factor receptor 2; IHC;
Keywords: APC; adenomatous polyposis coli; DNA; deoxyribonucleic acid; FQM; focused quantitative modeling; HER2; human epidermal growth factor receptor 2; HIV; human immunodeficiency virus; NGS; next generation sequencing; Pol; polymerase; RF; reduced fitness; TCGA
Keywords: Girdin; breast cancer; prognosis; HER2; subtype;
Sample preparation for detection of low abundance proteins in human plasma using ultra-high performance liquid chromatography coupled with highly accurate mass spectrometry
Keywords: AMI; acute myocardial infarction; DDA; data-dependent acquisition; HER2; human epidermal growth factor receptor 2; IAA; iodoacetamide; MARS; multiple affinity removal system; Pro-BNP; pro-brain natriuretic peptide; PSA; prostate specific antigen; Biomarke
Keywords: BC; breast cancer; NAC; neoadjuvant chemotherapy; HER2; human epidermal growth factor 2; ER; oestrogen receptor; PR; progesterone receptor; TNBC; triple negative breast cancer; PET/CT; positron emission tomography computed tomography; pCR; pathologic comp
Keywords: Hypersensitivity; Allergy; Infusion reaction; Monoclonal antibody; Desensitization; Challenge; Skin test; IgE; IgG; Cytokine release; ADCC; Antibody-mediated cell death; HER2; Human epidermal growth factor receptor 2; HSR; Hypersensitivity reaction; mAb;
Keywords: Esophagogastric cancer; HER2; Targeted therapy; Trastuzumab; Pertuzumab; TDM-1; Lapatinib;
Keywords: Next-generation sequencing; comprehensive genomic profiling; breast carcinoma; ERBB2; HER2; triple-negative breast cancer; tumour mutational burden; clinically relevant genomic alterations;
Keywords: Breast cancer; Hippocrates; Tamoxifen; Angelina Jolie; Herceptin; Radical mastectomy; Mammography; Aromatase inhibitors; BRCA1 and BRCA2; ER; HER2; Triple negative breast cancer (TNBC);
Keywords: ADCC; antibody-dependent cell-mediated cytotoxicity; AKT; protein kinase B; ATP; adenosine triphosphate; cfDNA; circulating free DNA; CISH; chromogenic in-situ hybridization; CTC; circulating tumor cells; EGFR; epithelial growth factor receptor; EMT; epit
Use of potential dietary phytochemicals to target miRNA: Promising option for breast cancer prevention and treatment?
Keywords: ALDH1; aldehyde dehydrogenase 1; AKT; protein kinase B; ARID4B; AT-rich interactive domain-containing protein 4B; BMI1; B-lymphoma Moloney murine leukemia virus insertion region-1; BMP1; bone morphogenetic protein 1; BRCA1; breast cancer 1; BIRC6; baculov
Keywords: Gastroesophageal; Gastric; MET; Epidermal growth factor receptor; HER2; ERBB2; Treatment; Targeted;
Keywords: Gastric cancer; Esophagogastric junction cancer; Gastroesophageal adenocarcinoma; HER2; VEGFR2; EGFR; MET; FGFR2;
Keywords: Dual EGFR/HER2 inhibitors; Resistance; T790M/L858R mutant EGFR; Irreversible inhibitors; ADMET; Absorption/Distribution/Metabolism/Excretion/Toxicity; Cbl; Casitas B-lineage Lymphoma; c-MET; cellular mesenchymal to epithelial transition factor; DM; double
Keywords: ATGs; Autophagy-related genes; HR; Hazard ratios; CI; Confidence intervals; eQTL; Expression quantitative trait loci; meQTL; Methylation quantitative trait loci; TCGA; The Cancer Genome Atlas; GTEx; Genotype-Tissue Expression; RSEM; RNA-Seq by Expectation
Keywords: EGFR; HER2; HDAC; Multitarget; Synergy; Resistance;
Keywords: BC; Breast cancer; CRM-1; Chromosome region maintenance 1; DBD; DNA-binding domain; E2; 17-beta-estradiol; EGF; Epidermal growth factor; ERα; Estrogen receptor alpha; Ful; Fulvestrant; GFP-ER; ER tagged with green fluorescent protein; HSP70; Heat shock p
Keywords: AFP; Alpha-fetoprotein; ANAs; Antinuclear antibodies; APCs; Antigen presenting cells; ANXA-1; Annexin A1; BRCA; Breast cancer susceptibility gene; CT; Cancer-testis; EGFR; Epidermal growth factor receptor; ELISA; Enzyme linked immunosorbent assay; HDR; Ho
Keywords: ACL; ATP citrate lyase; Akt; Protein kinase B; ASCT2; Alanine, serine, cysteine-preferring transporter 2; ASS; Argininosuccinate synthetase; BMI; Body mass index; CAF; Cancer-associated fibroblasts; ER; Estrogen receptor; FASN; Fatty acid synthase; GPC; G
Metal complexes of tridentate tripod ligands in medical imaging and therapy
Keywords: 2-TicNMe; tris(N-methylimidazol-2-yl)carbonil; 2-TipiPr2; tris(1,4-diisopropylimidazol-2-yl)phosphane; 4-TipH; tris(imidazole-4-yl)phosphane; AO; acridine orange; BBB; blood brain barrier; BBN; bombesin; bdmpza; 3,3-bis(3,5-dimethylpyrazol-1-yl)acetate; b
Keywords: ADT; androgen deprivation therapy; AR; androgen receptor; ASO; antisense oligonucleotide; CARN; castration-resistant Nkx3.1 expressing cells; CK; cytokeratin; CRPC; castration-resistant prostate cancer; DMBA; 7,12-dimethylbenz[a]anthracene; ECM; extracell
Keywords: T-DM1; Trastuzumab emtansine; MCC; 4-[N-maleimidomethyl] cyclohexane-1 carboxylate; HER2; human epidermal growth receptor-2; DM-1; emtansine; NRH; nodular regenerative hyperplasia; ER; estrogen receptor; PR; progesterone recepton; TCH; docetaxel, carbopla
Keywords: Sphingosine-1-phosphate; Sphingosine kinase; Estradiol; Breast cancer; FTY720/Fingolimod; ERα; estrogen receptor α; EGFR; epidermal growth factor receptor; ERE; estrogen response element; ERK; extracellular signal regulated kinase; E2; 17β-estradiol; H
Keywords: Gastric adenocarcinoma; Immunohistochemistry; Categorization; HER2; EBV
Keywords: Breast cancer; Metastasis; Prognosis; Estrogen receptor; Progesterone receptor; HER2; Race;
Keywords: Breast cancer; Estrogen receptor; HER2; Crosstalk; Combination therapy; Hormone therapy;
Keywords: Aboriginal; Asian; Breast cancer subtypes; Estrogen receptor; HER2;
Keywords: Biliary tract cancer; Cholangiocarcinoma; Gallbladder cancer; Genomics; Targeted therapy; Kras; Egfr; HER2; FGF; IDH
Keywords: Discordance; HER2; HR; Overall survival; Prognostic factor;
Keywords: EMT; epithelial to mesenchymal transition; ER; estrogen receptor; FBS; fetal bovine serum; GPCR; G-protein coupled receptors; Gy; gray; HA; histamine; HER2; human epidermal growth factor receptor 2; MMPs; matrixmetalloproteinases; P-Src; phosho-Src; PP2;
Keywords: ASC; apoptosis-associated speck-like protein containing a caspase recruitment domain; DAMPs; danger associated molecular patterns; EAE; experimental autoimmune encephalomyelitis; HER2; human epidermal growth factor related receptor 2; ERK; extracellular s
Keywords: Sphingosine-1-phosphate; Phospho-sphingosine kinase 1; Breast cancer; Lymphatic metastasis; HER2; Inflammation
Keywords: gastric cancer; targeted therapies; HER2; tyrosine kinase receptors
Keywords: Metastatic breast cancer; HER2; Trastuzumab; Pertuzumab; T-DM1; Lapatinib; Resistance; Management; Novel therapy;
Keywords: AA; accelerated approval; ALL; acute lymphoblastic leukemia; CCyR; complete cytogenetic response; CLL; chronic lymphocytic lymphoma; CML; chronic myeloid leukemia; CRC; colorectal carcinoma; CR; complete response; CRi; complete response with incomplete bl
Keywords: Deoxyelephantopin; DET derivatives; Triple-negative breast cancer; Lung metastasis; Paclitaxel; DEAD; diethyl azodicarboxylate; DET; deoxyelephantopin; DETD; deoxyelephantopin derivative; DMAP; dimethylaminopyridine; EDCI; 1-(3-dimethylaminopropyl)-3-ethy
Keywords: Biomarker; Client proteins; HER2; HSP90; Solid tumors;
Keywords: ALK; anaplastic lymphoma kinase; ALL; acute lymphoblastic leukemia; CLL; chronic lymphocytic leukemia; CML; chronic myelogenous leukemia; CNS; central nervous system; CRC; colorectal cancer; DTC; differentiated thyroid carcinoma; DUSP; dual specificity ph
Keywords: Quantum dots; Nanotechnology; Image-guided surgery; Cancer imaging; Nanoparticles; Breast cancer; Ach; acetylcholine; ALND; axillary lymph node dissection; BRET; bioluminance resonance energy transfer; C-dots; Cornell dots; CT; computerized tomography; C-
Keywords: CBL; casitas B-lineage lymphoma; CtxR; cetuximab-resistant; CtxS; cetuximab-sensitive; CRC; colorectal cancer; EGF; epidermal growth factor; EGFR; epidermal growth factor receptor; EMT; epithelial to mesenchymal transition; EPR; epiregulin; FDA; food and
Keywords: AM; adrenomedullin; AMF; autocrine motility factor; AML; acute myeloid leukemia; BCL; B-cell lymphoma; BCR; breakpoint cluster region; BM; bone marrow; CCL; chemokine (CâC motif) ligand; CML; chronic myeloid leukemia; ECM; extracellular matrix; EGF; epi
Keywords: Ab; Antibody; ABC; ATP-binding cassette; AIOM; Associazione Italiana di Oncologia Medica; ALCAM; Activated leukocyte cell adhesion molecule; APOD; Apolipoprotein D; AR; androgen receptor; AURKA; Aurora kinase A; AURKB; Aurora kinase B; BCS; Biopharmaceuti
Keywords: brain metastasis; breast cancer; HER2; trastuzumab; whole-brain irradiation
Keywords: Breast; Mammography; Calcification; ER; HER2
Keywords: Ado-trastuzumab emtansine; CNS metastasis; HER2; Lapatinib; Radiation;
Keywords: 5-FU; 5-fluorouracil; FDA; Food and Drug Administration; FISH; fluorescent in situ hybridization; GEJ; gastroesophageal junction; HER2; human epidermal growth factor receptor 2; IHC; immunohistochemistry; ISH; in situ hybridization; NBF; neutral buffered
Keywords: Single-molecule fluorescence imaging; Signal transduction; Dynamics; Transforming growth factor β receptor; Epidermal growth factor receptor; Total internal reflection fluorescence microscopy; TGF; transforming growth factor; EGFR; type I epidermal growt